<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2985087R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4945</journal-id>
<journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Med. Genet.</journal-id>
<journal-title-group>
<journal-title>Journal of medical genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-2593</issn>
<issn pub-type="epub">1468-6244</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31586943</article-id>
<article-id pub-id-type="pmc">7405652</article-id>
<article-id pub-id-type="doi">10.1136/jmedgenet-2019-106409</article-id>
<article-id pub-id-type="manuscript">NIHMS1597846</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Recurrent Homozygous Damaging Mutation in <italic>TMX2</italic>, Encoding a Protein Disulfide Isomerase, in Four Families with Microlissencephaly</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ghosh</surname>
<given-names>Shereen G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Breuss</surname>
<given-names>Martin W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Green</surname>
<given-names>Joshua D.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanley</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiaoxu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ross</surname>
<given-names>Danica</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Traynor</surname>
<given-names>Bryan J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alhashem</surname>
<given-names>Amal</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Azam</surname>
<given-names>Matloob</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Selim</surname>
<given-names>Laila</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bastaki</surname>
<given-names>Laila</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elbastawisy</surname>
<given-names>Hanan I.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Temtamy</surname>
<given-names>Samia</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zaki</surname>
<given-names>Maha S.</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gleeson</surname>
<given-names>Joseph G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurosciences, Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA 92093, USA</aff>
<aff id="A2"><label>2</label>Rady Childrenâ€™s Institute for Genomic Medicine, San Diego, CA 92025, USA</aff>
<aff id="A3"><label>3</label>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD 20892, USA</aff>
<aff id="A4"><label>4</label>Neurology Department, Johns Hopkins University, Baltimore, MD 21287, USA</aff>
<aff id="A5"><label>5</label>Department of Pediatrics, Prince Sultan Medical Military City, Riyadh 12233, Saudi Arabia</aff>
<aff id="A6"><label>6</label>Department of Pediatrics and Child Neurology, Wah Medical College, Wah Cantt, 47040 Pakistan</aff>
<aff id="A7"><label>7</label>Pediatric Neurology Department, Cairo University, Cairo 12613, Egypt</aff>
<aff id="A8"><label>8</label>Kuwait Medical Genetics Centre, Sabah Health District, Shuwaikh 44000, Kuwait</aff>
<aff id="A9"><label>9</label>Department of Ophthalmic Genetics, Research Institute of Ophthalmology, Sulaibikhat 12557, Egypt</aff>
<aff id="A10"><label>10</label>Center of Excellence for Human Genetics, National Research Centre, Cairo 12622, Egypt</aff>
<aff id="A11"><label>11</label>Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo 12622, Egypt</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1"><bold>Contributors:</bold> Contributors SGG and JGG conceptualized the study. SGG, LW, MB, JDG, XY, DR, and BJT performed the experiments and/or conducted analyses for the figures. VS, AA, MA, LS, LB, HA, MSZ, and JGG provided clinical information to conduct the study. JGG supervised the study. SGG and JGG wrote the original manuscript. All authors contributed to revisions and approved the final version.</p>
</fn>
<corresp id="CR1"><label>*</label>Please address correspondence to: Joseph G. Gleeson, Department of Neurosciences, University of California, San Diego, 92093, USA; <email>jogleeson@ucsd.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P29"><bold>Competing Interests:</bold> The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>57</volume>
<issue>4</issue>
<fpage>274</fpage>
<lpage>282</lpage>
<!--elocation-id from pubmed: 10.1136/jmedgenet-2019-106409-->
<abstract id="ABS1">
<sec id="S1">
<title>Background</title>
<p id="P2"><underline>P</underline>rotein <underline>D</underline>isulfide <underline>I</underline>somerase (PDI) proteins are part of the Thioredoxin (TRX) protein superfamily. PDIs are involved in the formation and rearrangement of disulfide bonds between cysteine residues during protein folding in the endoplasmic reticulum (ER) and are implicated in stress response pathways.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">Eight children from four consanguineous families residing in distinct geographies within the Middle East and Central Asia were recruited for study. All probands showed structurally similar microcephaly with lissencephaly (microlissencephaly) brain malformations. DNA samples from each family underwent whole exome sequencing (WES), assessment for repeat expansions, and confirmatory segregation analysis.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">An identical homozygous variant in <italic>TMX2</italic> (c.500G&gt;A), encoding Thioredoxin-related transmembrane protein 2, segregated with disease in all four families. This variant changed the last coding base of exon six, and impacted mRNA stability. All patients presented with microlissencephaly, global developmental delay, intellectual disability, and epilepsy. While <italic>TMX2</italic> is an activator of cellular <italic>C9ORF72</italic> repeat expansion toxicity, patients showed no evidence of <italic>C9ORF72</italic> repeat expansions.</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P5">The <italic>TMX2</italic> c.500G&gt;A allele associates with recessive microlissencephaly, and patients show no evidence of <italic>C9ORF72</italic> expansions. <italic>TMX2</italic> is the first PDI implicated in a recessive disease, suggesting a protein isomerization defect in microlissencephaly.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>TMX2</italic>
</kwd>
<kwd>thioredoxin</kwd>
<kwd>ER stress</kwd>
<kwd>microlissencephaly</kwd>
<kwd>protein disulfide isomerase</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>